FMT
ADVM

First Mercantile Trust’s Adverum Biotechnologies ADVM Stock Holding History

First Mercantile Trust’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-656
Closed -$65K – 857
2021
Q1 		$65K Sell
656
-57
-8% -$6.84K 0.01% 756
2020
Q4 		$77K Sell
713
-38
-5% -$4.7K 0.01% 738
2020
Q3 		$98K Buy
751
+290
+63% +$43.4K 0.01% 682
2020
Q2 		$96K Buy
+461
New +$81.6K 0.01% 683

Other funds holding ADVM

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

First Mercantile Trust's ADVM Position: Q2 2021 in Review

First Mercantile Trust sold out of Adverum Biotechnologies (ADVM) in Q2 2021, closing a stake of 656 shares — an estimated $65K sold.

First Mercantile Trust first reported a position in ADVM in Q2 2020 and held it in 4 quarters. The position peaked at $98K in Q3 2020. 118 funds tracked by Wall St. Rank hold ADVM as of Q2 2021.

  • First Mercantile Trust reported no remaining Adverum Biotechnologies position as of Q2 2021 after selling out during the quarter.
  • First Mercantile Trust sold 656 Adverum Biotechnologies shares in Q2 2021, an estimated $65K.
  • First Mercantile Trust first reported a position in Adverum Biotechnologies in Q2 2020 and held it in 4 quarters.
  • First Mercantile Trust's Adverum Biotechnologies position peaked at $98K in Q3 2020.
  • 118 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q2 2021.

Based on First Mercantile Trust's 13F filing for Q2 2021, filed 10 Aug 2021.